Ghent University Academic Bibliography

Advanced

WRN Promoter CpG island hypermethylation does not predict a favourable outcome for irinotecan-treated metastatic colorectal cancer patients

LJW Bosch, Y Luo, VV Lao, P Snaebjornsson, Geert Trooskens UGent, I Vlassenbroeck, S Mongera, W Tang, P Welcsh, J Herman, et al. (2015) JOURNAL OF PATHOLOGY. 237(suppl. 1). p.S40-S40
Please use this url to cite or link to this publication:
author
organization
year
type
conference (meetingAbstract)
publication status
published
subject
in
JOURNAL OF PATHOLOGY
J. Pathol.
volume
237
issue
suppl. 1
pages
S40 - S40
conference name
8th Joint meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain and Ireland
conference location
Dublin, Ireland
conference start
2015-06-23
conference end
2015-06-25
Web of Science type
Meeting Abstract
Web of Science id
000369952300180
JCR category
PATHOLOGY
JCR impact factor
7.381 (2015)
JCR rank
3/78 (2015)
JCR quartile
1 (2015)
ISSN
0022-3417
language
English
UGent publication?
yes
classification
C3
id
7154430
handle
http://hdl.handle.net/1854/LU-7154430
date created
2016-03-19 23:39:05
date last changed
2016-12-19 15:37:36
@inproceedings{7154430,
  author       = {Bosch, LJW and Luo, Y and Lao, VV and Snaebjornsson, P and Trooskens, Geert and Vlassenbroeck, I and Mongera, S and Tang, W and Welcsh, P and Herman, J and Koopman, M and Nagtegaal, I and Punt, CJA and Van Criekinge, Wim and Meijer, GA and Monnat, RJ and Carvalho, B and Grady, WM},
  booktitle    = {JOURNAL OF PATHOLOGY},
  issn         = {0022-3417},
  language     = {eng},
  location     = {Dublin, Ireland},
  number       = {suppl. 1},
  pages        = {S40--S40},
  title        = {WRN Promoter CpG island hypermethylation does not predict a favourable outcome for irinotecan-treated metastatic colorectal cancer patients},
  volume       = {237},
  year         = {2015},
}

Chicago
Bosch, LJW, Y Luo, VV Lao, P Snaebjornsson, Geert Trooskens, I Vlassenbroeck, S Mongera, et al. 2015. “WRN Promoter CpG Island Hypermethylation Does Not Predict a Favourable Outcome for Irinotecan-treated Metastatic Colorectal Cancer Patients.” In Journal of Pathology, 237:S40–S40.
APA
Bosch, LJW, Luo, Y., Lao, V., Snaebjornsson, P., Trooskens, G., Vlassenbroeck, I., Mongera, S., et al. (2015). WRN Promoter CpG island hypermethylation does not predict a favourable outcome for irinotecan-treated metastatic colorectal cancer patients. JOURNAL OF PATHOLOGY (Vol. 237, pp. S40–S40). Presented at the 8th Joint meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain and Ireland.
Vancouver
1.
Bosch L, Luo Y, Lao V, Snaebjornsson P, Trooskens G, Vlassenbroeck I, et al. WRN Promoter CpG island hypermethylation does not predict a favourable outcome for irinotecan-treated metastatic colorectal cancer patients. JOURNAL OF PATHOLOGY. 2015. p. S40–S40.
MLA
Bosch, LJW, Y Luo, VV Lao, et al. “WRN Promoter CpG Island Hypermethylation Does Not Predict a Favourable Outcome for Irinotecan-treated Metastatic Colorectal Cancer Patients.” Journal of Pathology. Vol. 237. 2015. S40–S40. Print.